Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanistic trial of Broncho-Vaxom (OM-85 BV) on innate immunity in COPD
2013-001940-71Phase 2Completed
- Sponsor
- OM Pharma
- Start
- Jul 2013
- Modality
- Whole Cell Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Broncho-Vaxom with Placebo (2 arms). Primary endpoint: Primary endpoint: change in phagocytic ability of monocyte-derived macrophages at Day 30. Started Jul 2013; status: completed.
02
Drugs
OM-85
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2013-001940-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001940-71.